BHCM
MRK icon

Brevan Howard Capital Management’s Merck MRK Stock Holding History

Brevan Howard Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.43M Sell
50,031
-4,998
-9% -$585K 0.05% 268
2026
Q1 		$6.62M Sell
55,029
-69,117
-56% -$7.98M 0.06% 178
2025
Q4 		$13.1M Buy
124,146
+31,029
+33% +$2.91M 0.14% 91
2025
Q3 		$7.82M Sell
93,117
-355,802
-79% -$29.3M 0.03% 147
2025
Q2 		$35.5M Buy
+448,919
New +$35.7M 0.21% 47
2025
Q1 		– Sell
-82,648
Closed -$8.22M – 1344
2024
Q4 		$8.22M Buy
82,648
+71,381
+634% +$7.36M 0.05% 83
2024
Q3 		$1.28M Buy
+11,267
New +$1.34M 0.01% 380
2024
Q2 		– Sell
-98,883
Closed -$13M – 1278
2024
Q1 		$13M Buy
98,883
+68,734
+228% +$8.47M 0.12% 40
2023
Q4 		$3.29M Buy
+30,149
New +$3.13M 0.04% 68

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brevan Howard Capital Management's MRK Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Merck (MRK) stake by 9.1% in Q2 2026, selling an estimated $585K and leaving 50,031 shares worth $6.43M. The position accounts for 0.05% of the portfolio, ranked #268.

Brevan Howard Capital Management first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. The position peaked at $35.5M in Q2 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Brevan Howard Capital Management held 50,031 shares of Merck worth $6.43M as of Q2 2026.
  • Brevan Howard Capital Management sold 4,998 Merck shares in Q2 2026, an estimated $585K.
  • Merck made up 0.05% of Brevan Howard Capital Management's portfolio in Q2 2026, its #268 holding.
  • Brevan Howard Capital Management first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Merck position peaked at $35.5M in Q2 2025.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.